Aethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 13, 2023PRNewsWire • 02/06/23
Aethlon Medical to Present at Sequire Biotechnology Conference on February 2nd, 2023PRNewsWire • 01/31/23
Aethlon Medical Announces Contract with NAMSA to Advance Hemopurifier Clinical Programs in CancerPRNewsWire • 01/30/23
Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate UpdatePRNewsWire • 11/14/22
Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2022PRNewsWire • 11/02/22
Aethlon Medical, Inc.'s (AEMD) CEO Chuck Fisher on Q1 2023 Results - Earnings Call TranscriptSeeking Alpha • 08/10/22
Aethlon Medical Announces First Quarter Financial Results and Provides Corporate UpdatePRNewsWire • 08/09/22
Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 9, 2022PRNewsWire • 08/03/22
Aethlon Medical Announces Publication of Peer-Reviewed Journal Article Describing Hemopurifier Resin Binding of Seven COVID-19 VariantsPRNewsWire • 07/28/22
Aethlon Medical Announces U.S. FDA Approval of Hemopurifier COVID-19 Study Protocol AmendmentPRNewsWire • 07/11/22
Aethlon Medical, Inc. (AEMD) CEO Dr. Chuck Fisher on Q4 2022 Results - Earnings Call TranscriptSeeking Alpha • 06/28/22
Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 28, 2022PRNewsWire • 06/21/22
Aethlon Medical Publishes In Vitro Studies Demonstrating Hemopurifier Resin Binding of Seven Clinically Relevant COVID-19 VariantsPRNewsWire • 05/02/22